Western blotting and RT-PCR were performed to validate the above results, and we found that knocking down MBD2 inhibited the expression of ABCB1, whereas the opposite effect was observed in CCA cells overexpressing MBD2 (Fig. 3D-E). This evidence concerns the gene ABCB1 and cholangiocarcinoma.